• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性黑色素瘤的瘤周治疗用干扰素-β。

Perilesional treatment of metastatic melanoma with interferon-beta.

机构信息

Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

出版信息

Clin Exp Dermatol. 2009 Oct;34(7):793-9. doi: 10.1111/j.1365-2230.2009.03207.x. Epub 2009 May 5.

DOI:10.1111/j.1365-2230.2009.03207.x
PMID:19438554
Abstract

Previous trials with various treatments have not shown satisfactory therapeutic results for cutaneous metastasis of malignant melanoma (MM). We report three patients who were treated with peritumoral injection of interferon (IFN)-beta for multiple skin metastases of MM. The metastatic tumours were infiltrated by significant numbers of CD8+ TIA+ cytotoxic lymphocytes, and the numbers of CD4+ cells and human leucocyte antigen-DR+ cells increased after IFN-beta injection. These results suggest that the peritumoral administration of IFN-beta enhanced the antitumour immune response against the MM, suggesting that it is a promising supportive treatment for skin metastasis of MM.

摘要

先前针对各种治疗方法的试验并未显示出对恶性黑色素瘤(MM)皮肤转移的令人满意的治疗效果。我们报告了三例接受瘤周注射干扰素(IFN)-β治疗 MM 多发性皮肤转移的患者。转移性肿瘤浸润了大量的 CD8+TIA+细胞毒性淋巴细胞,并且在 IFN-β注射后 CD4+细胞和人类白细胞抗原-DR+细胞的数量增加。这些结果表明,瘤周给予 IFN-β增强了针对 MM 的抗肿瘤免疫反应,表明它是 MM 皮肤转移的一种有前途的支持性治疗方法。

相似文献

1
Perilesional treatment of metastatic melanoma with interferon-beta.转移性黑色素瘤的瘤周治疗用干扰素-β。
Clin Exp Dermatol. 2009 Oct;34(7):793-9. doi: 10.1111/j.1365-2230.2009.03207.x. Epub 2009 May 5.
2
Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.静脉注射达卡巴嗪、阿糖胞苷和长春新碱联合辅助治疗以及局部注射β干扰素(DAV +β干扰素治疗)后恶性黑色素瘤免疫参数的变化
J Dermatol. 1998 Sep;25(9):569-72.
3
Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.两例下肢转移性恶性黑色素瘤患者接受了热灌注隔离肢体治疗,并同时输注卡铂或β-干扰素。
J Dermatol. 1996 Jan;23(1):6-15.
4
Intralesional therapy of metastatic spreading melanoma with beta-interferon.使用β-干扰素对转移性黑色素瘤进行瘤内治疗。
J Dtsch Dermatol Ges. 2006 Sep;4(9):743-6. doi: 10.1111/j.1610-0387.2006.06054.x.
5
The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.黑色素瘤患者单核细胞中细胞毒性介质的表达发生改变,且经α干扰素治疗后会增加。
Br J Dermatol. 2005 Apr;152(4):690-6. doi: 10.1111/j.1365-2133.2005.06512.x.
6
[Correlation between functional capability and phenotypic characteristics of peripheral blood lymphocytes in patients with malignant melanoma].[恶性黑色素瘤患者外周血淋巴细胞功能能力与表型特征的相关性]
Glas Srp Akad Nauka Med. 2002(47):121-36.
7
The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.CD8、CD4、CD68及人类白细胞抗原-D相关细胞在垂直生长期皮肤恶性黑色素瘤预后中的预测价值
Cancer. 2005 Sep 15;104(6):1246-54. doi: 10.1002/cncr.21283.
8
Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha.达卡巴嗪与α干扰素联合或单独治疗黑色素瘤患者期间免疫调节动力学的治疗意义
Neoplasma. 2001;48(3):175-81.
9
Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.接受白细胞介素12治疗的黑色素瘤患者外周肿瘤特异性细胞毒性T淋巴细胞的爆发以及记忆性CD8 + T细胞对转移灶的浸润
Cancer Res. 2000 Jul 1;60(13):3559-68.
10
Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.使用HLA-ABC半匹配黑色素瘤细胞系对黑色素瘤肿瘤浸润淋巴细胞培养物进行效应T细胞分析。
J Immunother. 2008 Sep;31(7):633-43. doi: 10.1097/CJI.0b013e3181822097.

引用本文的文献

1
Recent Advances in Molecular Research and Treatment for Melanoma in Asian Populations.亚洲人群黑色素瘤分子研究与治疗的最新进展
Int J Mol Sci. 2025 Jun 3;26(11):5370. doi: 10.3390/ijms26115370.
2
FAM210B activates STAT1/IRF9/IFIT3 axis by upregulating IFN-α/β expression to impede the progression of lung adenocarcinoma.FAM210B通过上调IFN-α/β表达激活STAT1/IRF9/IFIT3轴,以阻碍肺腺癌的进展。
Cell Death Dis. 2025 Feb 3;16(1):63. doi: 10.1038/s41419-025-07375-9.
3
Combining PD-1/PD-L1 blockade with type I interferon in cancer therapy.
将 PD-1/PD-L1 阻断与 I 型干扰素联合用于癌症治疗。
Front Immunol. 2023 Aug 24;14:1249330. doi: 10.3389/fimmu.2023.1249330. eCollection 2023.
4
Classification of PD-L1 expression in various cancers and macrophages based on immunohistocytological analysis.基于免疫细胞化学分析的各种癌症和巨噬细胞中 PD-L1 表达的分类。
Cancer Sci. 2022 Sep;113(9):3255-3266. doi: 10.1111/cas.15442. Epub 2022 Jun 15.
5
Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers.基质因子作为黑色素瘤和非黑色素瘤皮肤癌免疫治疗的靶点
Int J Mol Sci. 2022 Apr 6;23(7):4044. doi: 10.3390/ijms23074044.
6
Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock.臀部转移性表达PRAME的幼年梭形细胞黑色素瘤
Case Rep Oncol. 2020 Sep 21;13(3):1141-1144. doi: 10.1159/000510261. eCollection 2020 Sep-Dec.
7
Treatment of Advanced Melanoma: Past, Present and Future.晚期黑色素瘤的治疗:过去、现在与未来
Life (Basel). 2020 Sep 16;10(9):208. doi: 10.3390/life10090208.
8
Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells.通过Stat1/Stat2/IRF9持续的炎症信号传导与黑色素瘤细胞的阿米巴样表型相关。
Cancers (Basel). 2020 Aug 28;12(9):2450. doi: 10.3390/cancers12092450.
9
Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.免疫抑制细胞作为黑色素瘤和非黑色素瘤皮肤癌免疫治疗靶点的意义。
Biomolecules. 2020 Jul 22;10(8):1087. doi: 10.3390/biom10081087.
10
Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy.纳武单抗、伊匹单抗联合地诺单抗治疗抗PD1抗体耐药的晚期黏膜黑色素瘤患者获成功
Case Rep Oncol. 2020 Mar 24;13(1):271-275. doi: 10.1159/000506327. eCollection 2020 Jan-Apr.